Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.116 - June 2023
Paru le :
01/06/2023
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- The adoption and sustainability of digital therapeutics in justice systems: A pilot feasibility study. Wilde J.A., Zawislak K., Sawyer-Morris G., Hulsey J., Molfenter T., Taxman F.S., art. 104024.
- More than just 'free heroin': Caring whilst navigating constraint in the delivery of diamorphine assisted treatment. Poulter H.L., Walker T., Ahmed D., Moore H.J., Riley F., Towl G., et al., art. 104025.
- Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study. Lanièce Delaunay C., Klein M.B., Godin A., Cox J., Kronfli N., Lebouché B., et al., art. 104026.
- Unrecorded alcohol use in 33 European countries: Analyses of a comparative survey with 49,000 people who use alcohol. Manthey J., Braddick F., Lopez-Pelayo H., Shield K., Rehm J., Kilian C., art. 104028.
- Continuity and change in drug treatment: Regimes of control in Japan. Brewster D., Sagara S., art. 104029.
- Staying with the silence: Silence as affording care in online alcohol and other drug counselling. Savic M., Barnett A., Pienaar K., Carter A., Warren N., Sandral E., et al., art. 104030.
- Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic. Yücel S.G., Higgins C.D., Gupta K., Palm M., art. 104032.
- The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review. Manthey J., Jacobsen B., Hayer T., Kalke J., Lopez-Pelayo H., Pons-Cabrera M.T., et al., art. 104039.
- Hospital admissions for paracetamol poisoning declined following codeine re-scheduling in Australia. Noghrehchi F., Cairns R., Buckley N.A., art. 104040.
- Variation in adults' use of flavored tobacco products by sales restrictions in California jurisdictions. Timberlake D.S., Aviles J., Payan D.D., art. 104041.
- Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study. Malme K.B., Ulstein K., Finbraten A.-K., Wüsthoff L.E.C., Kielland K.B., Hauge J., et al., art. 104044.
- Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey. Varisco T., Patel H., Saadi R.A., Wanat M., Thornton D., art. 104045.
- The adoption and sustainability of digital therapeutics in justice systems: A pilot feasibility study. Wilde J.A., Zawislak K., Sawyer-Morris G., Hulsey J., Molfenter T., Taxman F.S., art. 104024.
- More than just 'free heroin': Caring whilst navigating constraint in the delivery of diamorphine assisted treatment. Poulter H.L., Walker T., Ahmed D., Moore H.J., Riley F., Towl G., et al., art. 104025.
- Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study. Lanièce Delaunay C., Klein M.B., Godin A., Cox J., Kronfli N., Lebouché B., et al., art. 104026.
- Unrecorded alcohol use in 33 European countries: Analyses of a comparative survey with 49,000 people who use alcohol. Manthey J., Braddick F., Lopez-Pelayo H., Shield K., Rehm J., Kilian C., art. 104028.
- Continuity and change in drug treatment: Regimes of control in Japan. Brewster D., Sagara S., art. 104029.
- Staying with the silence: Silence as affording care in online alcohol and other drug counselling. Savic M., Barnett A., Pienaar K., Carter A., Warren N., Sandral E., et al., art. 104030.
- Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic. Yücel S.G., Higgins C.D., Gupta K., Palm M., art. 104032.
- The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review. Manthey J., Jacobsen B., Hayer T., Kalke J., Lopez-Pelayo H., Pons-Cabrera M.T., et al., art. 104039.
- Hospital admissions for paracetamol poisoning declined following codeine re-scheduling in Australia. Noghrehchi F., Cairns R., Buckley N.A., art. 104040.
- Variation in adults' use of flavored tobacco products by sales restrictions in California jurisdictions. Timberlake D.S., Aviles J., Payan D.D., art. 104041.
- Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study. Malme K.B., Ulstein K., Finbraten A.-K., Wüsthoff L.E.C., Kielland K.B., Hauge J., et al., art. 104044.
- Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey. Varisco T., Patel H., Saadi R.A., Wanat M., Thornton D., art. 104045.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
J. MANTHEY ;
B. JACOBSEN ;
T. HAYER ;
J. KALKE ;
H. LOPEZ-PELAYO ;
M. T. PONS-CABRERA ;
U. VERTHEIN ;
M. ROSENKRANZ
|
2023
Dans International Journal of Drug Policy (Vol.116, June 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.116, June 2023) Article : Périodique
Background: For alcohol, regulating availability is an effective way to reduce consumption and harm. Similarly, the higher availability of medical cannabis dispensaries has been linked to increased cannabis consumption and harm. For recreational[...]